Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * patients ≥18 years on chronic dialysis due to end-stage renal disease. * competence to understand the study rationale, including potential risks and benefits associated with treatment, necessary for written informed consent.

inclusion criteria: * patients ≥18 years on chronic dialysis due to end-stage renal disease. * competence to understand the study rationale, including potential risks and benefits associated with treatment, necessary for written informed consent.

Nov. 9, 2021, 3:30 p.m. usa

inclusion criteria: - patients ≥18 years on chronic dialysis due to end-stage renal disease. - competence to understand the study rationale, including potential risks and benefits associated with treatment, necessary for written informed consent.

inclusion criteria: - patients ≥18 years on chronic dialysis due to end-stage renal disease. - competence to understand the study rationale, including potential risks and benefits associated with treatment, necessary for written informed consent.